• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

MedImmune (biologics division of AstraZeneca)

MedImmune is the global biologics research and development arm of AstraZeneca. MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres. *

 

	Start	1988-01-01 established_pre
	Group	AstraZeneca (Group)
	Predecessor	MedImmune Inc. (Nasdaq: MEDI)
	Industry	pharmaceutical
	Region	Gaithersburg, MD
	Country	United States (USA)
	Street	One MedImmune Way
	City	20878 Gaithersburg, MD
		Address record changed: 2015-01-18
Basic data	Employees	F: 1,001 to 5,000 (2005-05-14)
		* Document for �About Section�:
		Record changed: 2019-09-10

Advertisement

More documents for AstraZeneca (Group)

• [1] MiNA Therapeutics Ltd.. (1/7/20). "Press Release: MiNA Therapeutics Announces Research Collaboration with AstraZeneca in Metabolic Diseases". London....
• [2] Savara Inc.. (11/18/19). "Press Release: Savara Appoints Badrul Chowdhury, M.D., Ph.D as Chief Medical Officer". Austin, TX....
• [3] Innate Pharma S.A.. (11/13/19). "Press Release: Innate Pharma Third Quarter 2019 Report"....
• [4] AstraZeneca plc. (11/6/19). "Press Release: AstraZeneca Announces Three Large-scale Initiatives in China to Advance Global Medicine Research and Development"....
• [5] AstraZeneca plc. (10/30/19). "Press Release: AstraZeneca Divests Rights to Seroquel and Seroquel XR in Europe and Russia"....
• [6] AstraZeneca plc. (10/24/19). "Press Release: Year-to-Date and Q3 2019 Results"....
• [7] N-Side S.A.. (10/1/19). "Press Release: AstraZeneca Selects N-Side Suite for Clinical Trials to Optimize and Monitor Clinical Trial Supply Chain". Louvain-la-Neuve....
• [8] Innate Pharma S.A.. (9/23/19). "Press Release: Innate Pharma Announces Clinical Data Presentations on IPH5401 and Monalizumab at ESMO 2019". Marseille....
• [9] Cell Mogrify Ltd.. (9/9/19). "Press Release: Mogrify Appoints Dr. Jane Osbourn, OBE as Chair". Cambridge....
• [10] Theragnostics Ltd.. (9/5/19). "Press Release: Theragnostics Signs Agreement with AstraZeneca". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.